Capital Flow Monitor · Sponsors · CIK 1810038
Cancer IQ Inc.
2045 W Grand Avenue Ste B, CHICAGO, IL, 60612 · (312) 761-3360
Other Technology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$6.0M
Sold
$4.3M
% sold
71.4%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | D/A ·current | 506(b) | $6.0M | $4.3M | 71.4% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Olufeyikemi Olopade Ayodele — Executive Officer / Director, Chicago, IL
-
Mark Bakken — Director, Chicago, IL
8 other raises
- NOVIR, INC. $3.1M of $4.0M · 76.6%
- HealthX H1 Insights 2026, LLC $1.6M of $2.0M · 82.2%
- Vinyl Health, Inc. $1.0M of $2.5M · 40.0%
- KeyCare, Inc. $27.7M of $30.8M · 90.0%
- Amulet, PBC $758K of $1.0M · 75.8%
- Medsense Health, Inc. $4.0M of $4.2M · 94.7%
- Peerbridge Health, Inc. $7.2M of $8.0M · 89.8%
- Slot Check, Inc. $200K of $500K · 40.0%
- Joel Krikston — Director, Chicago, IL
- Haibo Lu — Executive Officer / Director, Chicago, IL
- Carladenise Edwards — Director, Chicago, IL
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.